Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)

Clinical trial NCT07433673 · RECRUITING

Trial details

NCT number: NCT07433673
Sponsor: Columbia University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Colon and Rectal Cancer

Start date: 2026-08-01
Primary completion: 2028-01-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.